We will independently review the status of research, the capabilities of researchers, patent position, research plans and budgets, markets and competition to provide potential investors with an assurance that a company's claims are realistic whilst alerting them to the risks.
The company has prepared expert reports for over 60 organisations, including:
- Acrux Limited
- BioDiem Limited
- Biotron Limited
- Cellestis Limited
- ChemGenex Pharmaceuticals LimitedClinuvel Limited
- CogState Limited
- Dia-B Tech Limited
- Eastland Medical Systems
(Australia and UK) - Ecobiotics Limited
- Genesis R&D Corporation (New Zealand)
- Iatia Limited
- Living Cell Technologies Limited
- Marshall Edwards Limited
- Medigen Limited (Taiwan)
- Medigard Limited
- Metabolic Pharmaceuticals Limited
- Norwood Abbey Limited
- Peplin Biotech Limited
- Phosphogenics Limited
- Prana Biotechnology Limited
- Starpharma Limited
- Vital Biotech Limited (Hong Kong)
- Virax Limited
- Virionyx Limited (New Zealand)
- Vividas Limited Mesoblast Limited